Interstitial Cystitis Association
Cafe ICA

Free online
monthly news digest


JOIN OUR MAILING LIST

 

Corporate & Foundation Funders

The ICA receives contributions from corporations and foundations who support our work.  We gratefully accept these contributions with the clear understanding that we retain full responsibility for, and control of, the shape and substance of our programs and activities.  Our supporters do not in any way dictate the content of our work.  The ICA does not accept advertisement dollars.

Ortho-McNeil is the distributor of Elmiron, the first and only oral medication FDA-approved specifically for the treatment of interstitial cystitis.

www.orthoelmiron.com/orthoelmiron

Astellas USA Foundation is the US philanthropic division of Astellas Pharma, Inc. of Japan. Astellas embraces an unrelenting commitment to R&D as a value-creating core of its business.

www.astellas.com

Medtronic Foundation is the philanthropic organization of Medtronic, Inc. The Medtronic Foundation supports a variety of Programs and Services for non-profit organizations aimed at empowering people with chronic disease.

www.medtronic.com/foundation

Bioniche Pharma USA are the makers of Rimso-50® (dimethyl sulfoxide irrigation, USP), the liquid form of DMSO, which is FDA approved for treating IC.

www.bionichepharmausa.com

AkPharma, Inc. makes Prelief, an over-the-counter food acid reducer shown to reduce bladder pain and urinary urgency. Independent research concluded that Prelief is superior to other IC interventions, including surgery, bladder instillations, and oral therapies. Results are published in Urology (Jan. 2008: Vol.17, 62 to 66).

www.prelief.com  or 800-994-4711

Alaven Pharmaceutical LLC the maker of CystoProtek, a patent-protected natural oral dietary supplement in softgel capsule form. CystoProtek has been clinically demonstrated to relieve symptoms associated with interstitial cystitis.

www.cysto-protek.com  888-317-0001

Desert Harvest provides special over-the-counter aloe vera formulas specifically designed to target the symptoms of interstitial cystitis.

www.desertharvest.com

Uroplasty is a global medical device company that develops, manufactures, and markets products for the minimally invasive treatment of voiding dysfunctions and pelvic disorders including urinary incontinence and overactive bladder symptoms.

www.uroplasty.com

Astra Tech, Inc., the maker of the LoFric hydrophilic catheters and kits for intermittent catheterization. LoFric is the only catheter in the world proven to reduce the risk of both UTIs and long-term complications. 100% latex-free.

www.lofric.com

Farr Labs developed patent-pending, clinically-proven formulas specifically designed for IC/PBS patients and CP/CPPS patients. Cysta-Q targets the urinary frequency, urgency, and pain of IC. A clinically proven over-the-counter supplement, read the studies published in peer-reviewed journals such as Techniques in Urology.

www.farrlabs.com or 877-284-3976

Liberator Medical Supply, Inc., a wholly owned subsidiary of Liberator Medical Holdings, Inc.,  is an accredited national provider of direct to consumer medical supplies, with a prime focus on sterile urinary catheters. We specialize in servicing patients covered by Medicare, Medicaid and private insurance. 

www.liberatormedical.com or 800-323-0914

We are making great strides thanks in part to the generous support from our corporate and foundation sponsors. Click on the links above to learn more about these sponsors and their products (many are commercial sites and may contain promotional material not necessarily endorsed by the ICA). The efforts of corporate and foundation sponsors help make positive changes:

    • Sponsors contribute to many of the vital programs and services offered by the ICA -- programs and services that make a difference by reaching out to IC patients, healthcare providers, and researchers
    • Private-public partnerships allow us to deliver quality education, support, and advocacy services to people with IC, caregivers, healthcare professionals, and researchers worldwide.
    • Corporate donations further the search for better treatment options and, ultimately, a cure for IC.

 

Revised March 20, 2009